Skip to main content
logo
Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
7.75
-0.29 (-3.61%)
At close: Aug 12, 2026, 4:00 PM EDT
7.75
0.00 (0.00%)
Pre-market: Aug 13, 2026, 5:57 AM EDT

Aura Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
804347411437397496
Market Cap Growth
89.51%-15.68%-6.01%10.25%-20.04%-
Enterprise Value
496.47219.69278.66230.65228.65347.93
Last Close Price
7.755.458.228.8610.5016.98

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
2.542.532.701.942.033.26
P/TBV Ratio
1.622.402.691.551.610.57

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.040.100.100.070.090.00
Net Debt / Equity Ratio
-0.87-0.93-0.87-0.91-0.86-0.97
Net Debt / EBITDA Ratio
2.241.141.392.472.844.30
Net Debt / FCF Ratio
2.971.491.633.203.024.29
Quick Ratio
16.567.8510.1318.3018.0620.27
Current Ratio
16.828.1510.7718.7618.8120.90
Return on Equity (ROE)
-53.34%-73.52%-46.01%-36.26%-33.78%-41.07%
Return on Assets (ROA)
-53.32%-64.03%-43.87%-35.42%-31.41%-38.71%
Return on Invested Capital (ROIC)
-487.45%-758.91%-493.53%-361.90%-378.54%-1137.65%
Return on Capital Employed (ROCE)
-57.58%-70.80%-46.85%-37.26%-32.93%-40.96%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-42.27%-21.52%-25.32%-32.34%-480.18%-1305.21%
Total Shareholder Return
-42.27%-21.52%-25.32%-32.34%-480.18%-1305.21%
SEC Filings: 10-K · 10-Q